Cargando…
Public health effectiveness of the FDA 510(k) clearance process : measuring postmarket performance and other select topics : workshop report /
"The Food and Drug Administration (FDA) is responsible for ensuring that medical devices are safe and effective before they go on the market. Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires a manufacturer of medical devices to notify FDA of its intent to market a medical dev...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Washington, D.C. :
National Academies Press,
©2011.
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Ia 4500 | ||
|---|---|---|---|
| 001 | EBSCO_ocn741137716 | ||
| 003 | OCoLC | ||
| 005 | 20231017213018.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 110713s2011 dcua ob 100 0 eng d | ||
| 010 | |a 2011284660 | ||
| 040 | |a VPI |b eng |e pn |c VPI |d IDEBK |d N$T |d CDX |d OCLCQ |d ORU |d OCLCQ |d ZMC |d YDXCP |d OCLCQ |d OCLCA |d DKDLA |d OCLCO |d OCLCQ |d COO |d OCLCA |d NLGGC |d OCLCA |d OCLCQ |d EBLCP |d DEBSZ |d OCLCQ |d OCLCA |d OCLCQ |d VT2 |d TOA |d AGLDB |d OCLCQ |d ZCU |d OCLCQ |d MERUC |d NJR |d OCLCO |d MERER |d OCLCO |d OCLCA |d BUF |d OCLCO |d OCLCQ |d OCLCO |d U3W |d OCLCQ |d OCLCO |d OCLCF |d OCLCO |d VNS |d OCLCO |d VTS |d ICG |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d S9I |d WYU |d STF |d U3G |d OCLCO |d DKC |d OCLCO |d OCLCQ |d M8D |d UX1 |d UKAHL |d OCLCQ |d OCLCA |d OCLCQ |d OCLCO |d SFB |d OCLCO |d OCLCQ | ||
| 019 | |a 741453582 |a 743034315 |a 816844536 |a 923283535 |a 1028798775 |a 1055338443 |a 1061045175 |a 1061050047 |a 1062893008 |a 1101722925 |a 1124352185 |a 1156398615 |a 1204381870 |a 1204384456 |a 1228603702 |a 1249240437 |a 1289848260 | ||
| 020 | |a 9780309162074 |q (electronic bk.) | ||
| 020 | |a 0309162076 |q (electronic bk.) | ||
| 020 | |a 1283134977 | ||
| 020 | |a 9781283134972 | ||
| 020 | |z 0309162068 | ||
| 020 | |z 9780309162067 | ||
| 020 | |a 9780309215114 |q (e-book) | ||
| 020 | |a 0309215110 | ||
| 029 | 1 | |a AU@ |b 000051518570 | |
| 029 | 1 | |a AU@ |b 000066764898 | |
| 029 | 1 | |a AU@ |b 000068808701 | |
| 029 | 1 | |a DEBBG |b BV043116963 | |
| 029 | 1 | |a DEBBG |b BV044109228 | |
| 029 | 1 | |a DEBSZ |b 421588322 | |
| 029 | 1 | |a DEBSZ |b 452578256 | |
| 029 | 1 | |a GBVCP |b 803605714 | |
| 035 | |a (OCoLC)741137716 |z (OCoLC)741453582 |z (OCoLC)743034315 |z (OCoLC)816844536 |z (OCoLC)923283535 |z (OCoLC)1028798775 |z (OCoLC)1055338443 |z (OCoLC)1061045175 |z (OCoLC)1061050047 |z (OCoLC)1062893008 |z (OCoLC)1101722925 |z (OCoLC)1124352185 |z (OCoLC)1156398615 |z (OCoLC)1204381870 |z (OCoLC)1204384456 |z (OCoLC)1228603702 |z (OCoLC)1249240437 |z (OCoLC)1289848260 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a RA399.A3 |b P82 2011eb | |
| 060 | 4 | |a 2011 H-653 | |
| 060 | 4 | |a W 26 | |
| 072 | 7 | |a HEA |x 021000 |2 bisacsh | |
| 082 | 0 | 4 | |a 362.10685 |
| 049 | |a UAMI | ||
| 245 | 0 | 0 | |a Public health effectiveness of the FDA 510(k) clearance process : |b measuring postmarket performance and other select topics : workshop report / |c Theresa Wizemann, editor ; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies. |
| 246 | 1 | 7 | |a FDA 510(k) clearance process |
| 260 | |a Washington, D.C. : |b National Academies Press, |c ©2011. | ||
| 300 | |a 1 online resource (xiv, 118 pages) : |b illustrations (chiefly color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 504 | |a Includes bibliographical references. | ||
| 505 | 0 | 0 | |t Introduction -- |t Food and Drug Administration Postmarket Surveillance Activities and Recall Studies of Medical Devices -- |t Non-Food and Drug Administration Sources of Adverse Event Data -- |t Postmarket Surveillance of Medical Devices: Panel Discussion -- |t Other Select Topics -- |g Appendix A: |t Workshop Agenda -- |g Appendix B: |t Biographic Information on Invited Speakers, Panelists, and Authors of Commissioned Papers -- |g Appendix C: |t 510(k) Premarket Notification Analysis of FDA Recall Data -- |g Appendix D: |t Trustworthy Medical Device Software. |
| 520 | |a "The Food and Drug Administration (FDA) is responsible for ensuring that medical devices are safe and effective before they go on the market. Section 510(k) of the Federal Food, Drug, and Cosmetic Act requires a manufacturer of medical devices to notify FDA of its intent to market a medical device at least 90 days in advance. That window of time allows FDA to evaluate whether the device is substantially equivalent to a product already legally on the market (called a predicate), in which case the device does not need to go through the premarket approval (PMA) process. As part of its assessment of the FDA's premarket clearance process for medical devices, the Institute of Medicine (IOM) held a workshop on July 28, 2010 to discuss how medical devices are monitored for safety after they are available to consumers. Its primary focus was on monitoring the safety of marketed medical devices, including FDA's postmarket surveillance activities, analysis of safety concerns that resulted in medical device recalls, and non-FDA sources of adverse-event information. Public Health Effectiveness of the FDA 501(K) Clearance Process summarizes the views of the workshop participants."--Publisher's description | ||
| 588 | 0 | |a Print version record. | |
| 590 | |a eBooks on EBSCOhost |b EBSCO eBook Subscription Academic Collection - Worldwide | ||
| 610 | 1 | 0 | |a United States. |b Food and Drug Administration |v Congresses. |
| 610 | 1 | 2 | |a United States |b Food and Drug Administration |
| 610 | 1 | 7 | |a United States. |b Food and Drug Administration. |2 fast |0 (OCoLC)fst00549734 |
| 650 | 0 | |a Public health |x Equipment and supplies |x Standards |z United States |v Congresses. | |
| 650 | 0 | |a Public health |z United States |v Congresses. | |
| 650 | 1 | 2 | |a Device Approval |x standards |
| 650 | 2 | 2 | |a Device Approval |x legislation & jurisprudence |
| 650 | 2 | 2 | |a Equipment Safety |x standards |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Santé publique |z États-Unis |v Congrès. | |
| 650 | 7 | |a HEALTH & FITNESS |x Safety. |2 bisacsh | |
| 650 | 7 | |a Public health. |2 fast |0 (OCoLC)fst01082238 | |
| 651 | 7 | |a United States. |2 fast |0 (OCoLC)fst01204155 | |
| 655 | 2 | |a Congress | |
| 655 | 4 | |a Electronic resource. | |
| 655 | 7 | |a Conference papers and proceedings. |2 fast |0 (OCoLC)fst01423772 | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congrès. |2 rvmgf | |
| 700 | 1 | |a Wizemann, Theresa M. | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process. | |
| 776 | 0 | 8 | |i Print version: |t Public health effectiveness of FDA 510(k) clearance process. |d Washington, D.C. : National Academies Press, ©2011 |z 0309162068 |w (OCoLC)694600804 |
| 856 | 4 | 0 | |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=372504 |z Texto completo |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH36559509 | ||
| 938 | |a Coutts Information Services |b COUT |n 18019326 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3378791 | ||
| 938 | |a EBSCOhost |b EBSC |n 372504 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 313497 | ||
| 938 | |a YBP Library Services |b YANK |n 7082321 | ||
| 994 | |a 92 |b IZTAP | ||